Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set.

ABSTRACT: The primary cause of morbidity and mortality in patients with multiple myeloma (MM) is an infection. Therefore, there is great concern about susceptibility to the outcome of COVID-19-infected patients with MM. This retrospective study describes the baseline characteristics and outcome data of COVID-19 infection in 650 patients with plasma cell disorders, collected by the International Myeloma Society to understand the initial challenges faced by myeloma patients during the COVID-19 pandemic. Analyses were performed for hospitalized MM patients. Among hospitalized patients, the median age was 69 years, and nearly all patients (96%) had MM. Approximately 36% were recently diagnosed (2019-2020), and 54% of patients were receiving first-line therapy. Thirty-three percent of patients have died,

SUBMITTER: Chari A 

PROVIDER: S-EPMC7759145 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature